Delta Electronics to acquire ACT Genomics from Prenetics for $72m.

Delta Electronics, a Taiwan-based provider of power management and smart green solutions, agreed to acquire ACT Genomics, an oncology-focused genomics and diagnostics company, from Prenetics, a Hong Kong-based consumer health sciences company, for $72m. "Population ageing and the rising incidence of cancer worldwide are amplifying the demand for advanced healthcare. ACT Genomics has established a leading position in the NGS field in Asia, and we believe that its innovative technology can complement Delta’s resources and healthcare solutions portfolio," Ping Cheng, Delta Electronics Chairman and CEO.